EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Navigating complexity: The Supera’s triumph in femoropopliteal lesions

Luis Loureiro iD, Andreia Pinelo, Carlos Veterano iD, Henrique Rocha, João Castro, Rui Machado

Vascular · 2025

DOI: 10.1177/17085381241246321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular, 2025. Verfasst von Luis Loureiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Angiology and Vascular Surgery Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Peripheral Arterial Disease, Stents. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The femoropopliteal sector endovascular treatment is particularly challenging due to its high tortuosity and torsional forces. Better results are still needed to ensure the long-term patency of stenting in this area. The Supera stent appears to change this paradigm.

Methods

This single-center retrospective cohort study aims to evaluate the efficacy and safety of femoropopliteal stenting with Supera in a real-world population. Seventy-nine patients were treated between January 2015 and December 2020, and the results are reported with a median follow-up of 28 months.

Results

Indications for revascularization were chronic limb-threatening ischemia with tissue loss (73.6%) or ischemic rest pain (17.7%) and claudication (7.6%). Thirty-six patients (45.6%) were classified as GLASS stage III according to the Global Limb Anatomic Staging System, with 65.8% and 30.4% in grades 3 and 4 of femoropopliteal and infrapopliteal sectors, respectively. The 36-month primary, primary-assisted, and secondary patency rates were 68.6%, 72.0%, and 79.0%, respectively, with an amputation-free survival rate of 86.6%. There was no significant difference between primary patency rates in GLASS stages I–II compared with GLASS stage III (36-month primary patency rates of 72% vs 63% respectively, p = 0.342) nor in amputation-free survival (88% vs 84%, p = 0.877). After adjusting for potential confounders, only the stent conformation significantly affected the primary patency rates, with a higher hazard of reintervention for the elongated (HR = 3.179; p = 0.36; CI 1.081–9.347) and the compressed (HR = 3.014; p = 0.42; CI 1.039–8.746) forms.

Conclusions

The 36-month patency of the Supera stents in our real-world cohort was similar to other reported series. The GLASS stage did not interfere with the stent patency, proving it is a good choice even in the most adverse anatomy patients. Only the non-nominal stent conformation affected the primary patency rates in our patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Popliteal ArteryFemoral ArteryPeripheral Arterial DiseaseStentsEndovascular ProceduresIschemiaHumansRetrospective StudiesMaleFemaleAgedVascular PatencyTime FactorsMiddle AgedRisk FactorsLimb SalvageAged, 80 and overTreatment OutcomeAmputation, SurgicalProsthesis Design

Stichwörter der Autor:innen

Femoropoplitealchronic limb-threatening ischemiastentsvascular surgery

Autor:innen und Institutionen

  • Angiology and Vascular Surgery Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal.

ORCID-Profile: Luis Loureiro, Carlos Veterano

Zitieren

APA

Loureiro, L., Pinelo, A., Veterano, C., Rocha, H., Castro, J., & Machado, R. (2025). Navigating complexity: The Supera’s triumph in femoropopliteal lesions. Vascular. https://doi.org/10.1177/17085381241246321

Vancouver

Loureiro L, Pinelo A, Veterano C, Rocha H, Castro J, Machado R. Navigating complexity: The Supera’s triumph in femoropopliteal lesions. Vascular. 2025. doi:10.1177/17085381241246321

BibTeX
@article{Loureiro2025,
  author = {Loureiro, Luis and Pinelo, Andreia and Veterano, Carlos and Rocha, Henrique and Castro, João and Machado, Rui},
  title = {Navigating complexity: The Supera’s triumph in femoropopliteal lesions},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241246321}
}
Kostenlos starten →